In my humbel opinion, and watching all my small cap biotech company stocks rising on share volumes. If Obamacare verdict goes as a No vote on Supreme's vote, We will see the industry go forward in a positive way. It unleashes start-ups to spend cash to get clinicals moving forward. Ventured with a new board on ALQA looks promising, but hey maybe I need more meds...
This one is starting to bother me. 10 K - I believe stated they would stop wages for key people if earnings were poor. Well they were awful and new wages for one key person are $200,000 plus and huge stock purchase options. I believe they also stated expanded production growth. Same facility with approximately same staff. Stock has been diluted by several times over the last several years. Are items worded carefully to protect or is Alliqua inc. the real deal? So far it is the heads of company and investment company to take home any money. Huh - they are one and the same group????
Hopefully I am just paranoid. Many other boards appear to have the same concerns. Harbor View - step up and show your ethics/honor.
I believe that your criticism is absolutely correct-I had trumpeted this assessment for a very long time...I finally gave up as few others commented on my observations of this apparently self serving management.